‹

News & Bulletin UpdatesNews

INDIA DOMESTIC PRICES – WHAT IS GOING ON?

DMF surges Rs 7 weekly as powerful monthly rally reaches Rs 33 – India Domestic Prices – What Is Going On?

IndianPetroChem

This edition covers:

  • DMF surges Rs 7 weekly as powerful monthly rally reaches Rs 33
  • EDC slips Rs 3 in Pipavav but maintains firm longer-term recovery trend
  • Benzene jumps Rs 6 in Mumbai as prices revisit their yearly high
  • Ethyl acetate rebounds Rs 2 weekly but remains below last month's levels
  • Nitrobenzene climbs Rs 5 in Delhi as monthly gains hit Rs 23
  • Acrylamide climbs Rs 6 weekly as prices approach their strongest yearly levels
  • Paraformaldehyde rebounds Rs 5 in Delhi but remains below last month's benchmark
  • C5 gains Rs 2 in Delhi as monthly recovery approaches recent high
  • Maleic anhydride plunges Rs 56 weekly, erasing momentum after recent record high
  • VAM gains Rs 2.50 weekly but broader monthly price weakness persists
  • Phthalic anhydride slips Rs 3 but retains firm monthly gains in Delhi
  • Hydrogen peroxide rises Rs 2 weekly as gradual market recovery gathers momentum
  • Palm wax gains Rs 2 as momentum pushes prices toward yearly highs
  • Caustic soda flakes tumble Rs 4 as weekly selling disrupts recent recovery
  • Glycerine falls Rs 4 in Delhi as monthly losses reach Rs 29
  • Sulphuric acid falls Rs 3 in Delhi as short-term market weakness deepens
  • Heavy soda ash edges Rs 0.75 higher but monthly weakness remains intact
  • Mancozeb surges Rs 15 in Delhi as powerful rally nears recent peak
  • PP prices hold steady in Delhi as strong monthly recovery remains intact
  • PBT holds steady in Ahmedabad as three-month gains reinforce market strength
  • ABS slips Rs 3 in Delhi but holds steady against monthly benchmark
  • SBR rises Rs 2 in Ahmedabad as prices reach fresh recent highs
  • SEBS gains Rs 3 in Ahmedabad as September rally reaches fresh high

The complete bulletin is available to subscribers.

Read the complete bulletin

Request a free trial and our team will set up your access. Subscribers log in and return to this bulletin in full.

Questions about access? Contact our team
← Browse more news & analysis